Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MPH Health Care AG operates as an investment holding company focused primarily on high-growth healthcare segments in Germany and Europe. Its direct holdings include M1 Kliniken AG (market leader in aesthetic/plastic beauty medicine), CR Capital AG (real estate), and HAEMATO AG (import/distribution of pharmaceuticals including COVID diagnostics). Through these subsidiaries, it covers a broad spectrum of healthcare services from aesthetic treatments to pharmaceutical distribution for chronic diseases such as cancer, HIV/AIDS, neurology, and rheumatology. The group also invests in ventures related to patient-specific cytostatic solutions and innovative healthcare start-ups. Clinical results are reported at the level of portfolio companies rather than at the holding level.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MPH Health Care.